Portfolio Management Services (PMS)Compare Schemes
Merisis Multicap Portfolio vs Valcreate Lifesciences and Specialty Opportunities
Add SchemeGrowth of ₹1 Crore
Merisis Multicap Portfolio
Valcreate Lifesciences and Specialty Opportunities
Return for the risk
3 yrs return
5%
10%
15%
20%
25%
NIFTY 50 Total Return Index · 9%
10%
20%
30%
Volatility • 3 yrs deviation
1 Month
3.02%
6.35%
6 Months
14.30%
17.95%
1 Year
18.52%
21.71%
3 Years
11.27%
19.34%
5 Years
8.98%
—
Since Inception
16.57%
19.34%
Fund Age
6 yrs 6 mo
3 yrs 6 mo
AUM
₹4.79 Cr
₹18.73 Cr
Alpha – 1 Year
18.87%
16.99%
Alpha – 3 Years
2.27%
7.25%
Information Ratio – 3 Years
0.39
0.85
Volatility – 1 Year
19.72%
22.22%
Volatility – 3 Years
16.55%
20.72%
Beta – 1 Year
1.05
0.87
Beta – 3 Years
0.99
0.89
Sharpe Ratio – 1 Year
0.68
0.75
Sharpe Ratio – 3 Years
0.41
0.85
Worst Rolling Year
3.70%
—
Value at Worst Rolling Year
₹1.04 Cr
—
Deepest Drawdown
−22.25%
—
Recovery Period
511 days
—
1-Year Rolling Windows Positive
100.00%
—
Median Rolling Year
10.81%
—
5-Year Rolling Windows Positive
100.00%
—
Market-Cap Mix
L 4% · S 64%
—
Number of Stocks
9
—
Portfolio P/E
13.20
—
Top 5 Holdings
Cash & Cash Equivalent · 14.62%
Tamilnad Mercantile Bank Ltd · 11.18%
Northern Arc Capital Ltd · 9.26%
Wockhardt Ltd · 8.90%
Glaxosmithkline Pharmaceuticals Ltd · 8.24%
Sharda Cropchem Ltd · 11.13%
Kwality Pharmaceuticals Ltd · 5.72%
Sumitomo Chemical India Ltd · 5.72%
Vinati Organics Ltd · 5.51%
Rallis India Ltd · 5.34%
Top Sectors
Financial Services · 34.78%
Healthcare · 17.14%
Automobile and Auto Components · 7.77%
—
Fixed Fee
2.50% / yr
2.50% / yr
Performance Fee / Plan
Fixed Plan
Fixed Plan
Exit Load (Y1 / Y2 / Y3)
3% / 2% / 1%
0% / 0% / 0%